For mild to moderate reactions during the infusion, consider slowing or stopping the infusion. Upon resolution of these reactions, may reinitiate at a lower infusion rate and/or with histamine-1 receptor antagonists, histamine-2 receptor antagonists, acetaminophen, and/or corticosteroids. Discontinue...
Upon resolution of these reactions, may reinitiate at a lower infusion rate and/or with histamine-1 receptor antagonists, histamine-2 receptor antagonists, acetaminophen, and/or corticosteroids. Discontinue the infusion if the mild to moderate reactions reoccur. Discontinue the infusion if severe ...
During infusion, mild to moderate infusion reactions may improve following slowing or suspension of the infusion, and upon resolution of the reaction, reinitiation at a lower infusion rate and/or therapeutic administration of antihistamines, acetaminophen, and/or corticosteroids. For patients that do...
Infusionappointments17 Monitoryourprogress18 Lookingformoreinformationorsupport?19 3 INTRODUCTION Yourdoctorhas prescribedREMICADE®Thisbooklethasbeendesigned (iniximab)totreatyourtohelpyou: •UnderstandhowREMICADE Crohn’sdiseasebecause worksandhowitcanimprove ...
Infusion reactions with infliximab occur infrequently and can generally be managed with slowing the infusion rate and/or medical treatment (Terajima et al 1998; Braun and Sieper 2003; Cheifetz et al 2003). It has been shown that patients with RA have a higher risk of lymphoma and leukemia ...
Infusion reactions with infliximab occur infrequently and can generally be managed with slowing the infusion rate and/or medical treatment (Terajima et al 1998; Braun and Sieper 2003; Cheifetz et al 2003). It has been shown that patients with RA have a higher risk of lymphoma and leukemia ...